Dr. Reddy's Laboratories announces SBTi targets
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Subscribe To Our Newsletter & Stay Updated